期刊文献+

SEA在抗癌药物中的应用及其研究进展

Application of SEA in Anti-tumor Therapy and lts Research Progress
下载PDF
导出
摘要 超抗原是一种强大的T细胞激活剂,金黄色葡萄球菌肠毒素A(SEA)是由葡萄球菌产生的一种外毒素,为目前研究最广泛的一种超抗原,也是唯一进入癌症治疗临床试验的超抗原。介绍了SEA在抗癌药物中的应用及其研究进展。 Staphylococcal enterotoxi A (SEA) is a kind of strong activator for T cells, which is a sort of exotoxin pro- duced by Staphylococcus. Currently,only SEA is applied into clinical trial among all of Superantigens and is studied most comprehensively. To introduce the application of SEA in anti-tumor therapy and its research progress.
出处 《河北化工》 2012年第8期9-10,38,共3页 Hebei Chemical Industry
关键词 SEA 超抗原 免疫 癌细胞 SEA superantigen immunization cancer cell
  • 相关文献

参考文献7

  • 1黄常新,王青青.超抗原的免疫功能及其作用机制研究现状[J].国外医学(免疫学分册),2003,26(6):287-292. 被引量:7
  • 2K. Petersson,G. Forsberg & B. Walse. Interplay Between Superantigens and Immunoreeeptors[J]. Scandinavian Journal of Immunology, 2004,59 : 345-355.
  • 3韩红星,孔繁华,奚永志.MHC在免疫识别作用中的研究进展[J].免疫学杂志,2000,16(z1):15-17. 被引量:7
  • 4李亚斐,朱锡华.超抗原与自身免疫病[J].免疫学杂志,2001,17(z1):68-71. 被引量:3
  • 5Dohlsten M,Sundstedt A,Bioklund M,et al. Superantigen-induce cytokines suppress growth of human colon-carcinoma cells[J]. Cancer, 1993,54:482.
  • 6Abe J, Ito Y, Onimaru M, Kohsaka T, et al. Characterization and distribution of 8 new enterotoxin-related superantigen produced by Staphyloeoceus aureas [J]. Microbiol Immune, 2000,44 (2) :79 -88.
  • 7Newton DW, Dohlsten M, Lando PA, et al. MHC class II-independent, V beta-specific activation of T cells by superantigen mutants fused to anti-tumor Fab fragments:implications for use in treatment ofhuman colon carcinoma[J]. Int J Mol Med, 1998,1 (1) :157-162.

二级参考文献31

  • 1[1]Du C, Sriram S. induction of interleukin-12/p40 by superantigens in macrophages is mediated by activation of nuclear factor-kappaB [J]. Cell Immunol, 2000, 199(1): 50-57.
  • 2[2]Conrad B, Weldmann E, Trucco G, et al. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetology [J]. Nature, 1994, 371(6 495): 351- 355.
  • 3[3]Conrad B, Weissmahr RN, Boni J, et al. A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes [J]. Cell, 1997,90(2): 303 - 313.
  • 4[4]Kim A, Jun HS, Wong L, et al. Human endogenous retrovirus with a high genomic sequence homology with IDDMK(1.2)22 is not specific for Type Ⅰ (insulin-dependent) diabetic patients but ubiquitous[J]. Diabetologia, 1999,42(4): 413-418.
  • 5[5]Acha Orbea H, Mitchell DJ, Timmerman L, et al. Limited heterogeneity of T cell receptors from lymphocyte mediating autoimmune encephalomyelitis allows specific immune intervention [J]. Cell, 1988, 54(2): 263 - 273.
  • 6[6]Brocke S, Gaur A, Piercy C, et al. Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen [J]. Nature, 1993, 365(6 447): 642-644.
  • 7[7]Das MR, Cohen A, Zamvil SS, et al. Prior exposure to superantigen can inhibit or exacerbate autoimmune encephalomyelitis: T-cell repertoire engaged by the autoantigen determines clinical outcome[J]. J Neuroimmunol, 1996, 71(1,2): 3-10.
  • 8[8]Sawitzke A, Joyner D, Knudtson K, et al. Anti-MAM antibodies in rheumatic disease: evidence for a MAM-like superantigen in rheumatoid arthritis[J]? J Rheumatol, 2000,27(2): 358- 364.
  • 9[9]Kraft M, Filsinger S, Kramer KL, et al. Synovial fibroblasts as target cells for staphylococcal enterotoxin-induced T-cell cytotoxicity[J]. Immunology, 1998,93(1): 20 - 25.
  • 10[10]Fischer P, Uttenreuther Fischer MM, Gaedicke G. Superantigens in the aetiology of Kawasaki disease [J]. Lancet, 1996,348(9 021) :202.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部